Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × Pharmaceutical Preparations × Clear all

NCT05263219 2023-06-22

DEB-TACE+HAIC vs. HAIC for Large HCC

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT02973685 2023-06-12

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT03791918 2019-05-02

Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria

Phase 3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular